The National Heart, Lung, and Blood Institute (NHLBI) Science Moving towArds Research Translation and Therapy (SMARTT ) Program supports the translation of novel discoveries into successful new therapies for heart, lung, and blood diseases by providing free, confidential, and rapid preclinical development services to investigators.
To accelerate translation of research from bench to bedside by providing services that support pre-clinical studies and regulatory submissions. These services are:
- Performed at no cost to the investigator
- Preclinical study planning & regulatory support
- Pharmacology & toxicology services
- Manufacturing of small molecules and non-biologics
- Manufacturing of biologics
If you are interested in using the service please visit the SMARTT homepage for complete details on the process and/or to subscribe to their newsletter.